Skip to main content
Top
Published in: Inflammation 1-2/2007

01-04-2007

Endothelins Mediate Neutrophil Activation, ProMMP-9 Release and Endothelial Cell Detachment

Authors: Monica C. Toffoli, Bichoy H. Gabra, Catarina F. P. Teixeira, Pierre Sirois, Sonia Jancar

Published in: Inflammation | Issue 1-2/2007

Login to get access

Abstract

Neutrophils isolated from human peripheral blood added to a monolayer of human endothelial cells (ECV-304 cell line) stimulated with LPS (100 ng ml−1) resulted in: (a) neutrophil activation, measured by spreading and release of leukotriene B4 (LTB4); (b) neutrophil degranulation, measured by release of matrix pro-metalloproteinase-9 (proMMP-9) and (c) loss of the monolayer integrity due to detachment of the endothelial cells. Stimulation of endothelial cells with tumor necrosis factor-α (TNF-α 10 ng ml−1) or interleukin-1 (IL-1; 10 ng ml−1) induced a similar dose-dependent increase in the neutrophil activation and endothelial cell detachment. Pre-treatment of LPS-activated ECV-304 cells with [Phe22]BigET-1(19–37) (10−9 M; an inhibitor of endothelin converting enzyme (ECE)) or addition of BQ-123 (10−6 M; a selective endothelin A (ETA) receptor antagonist) to the co-cultures, significantly reduced neutrophil spreading (50–70% inhibition) as well as the levels of LTB4 (70–100% inhibition) and proMMP-9 (40–50% inhibition) in the co-culture supernatants. In addition, the detachment of endothelial cells was also reduced (60–75% inhibition). Moreover, the exogenous addition of ET-1 (10−9 M) to neutrophil suspensions induced neutrophil spreading and release of LTB4 and proMMP-9. Taken together, these findings indicate that neutrophils added to stimulated endothelial cells in the co-culture system employed in this study, get activated by products of these cells and degranulate. In parallel, the detachment of endothelial cell monolayer from the culture plates, possibly by the action of neutrophil granule-derived gelatinases, is observed. Endothelins (ETs) produced by the endothelial cells are suggested to play an essential role in these phenomena.
Literature
1.
go back to reference Inoue, A., M. Yanagisawa, S. Kimura, Y. Kasuya, T. Myauchi, K. Goto, and T. Masaki. 1989. The human endothelin family; three structurally and pharmacologically distinct isopeptides predicted by separated genes. Proc. Natl. Acad. Sci. U. S. A. 86:2863–2867.PubMedCrossRef Inoue, A., M. Yanagisawa, S. Kimura, Y. Kasuya, T. Myauchi, K. Goto, and T. Masaki. 1989. The human endothelin family; three structurally and pharmacologically distinct isopeptides predicted by separated genes. Proc. Natl. Acad. Sci. U. S. A. 86:2863–2867.PubMedCrossRef
2.
go back to reference Yanagisawa, M., H. Kuhihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415.PubMedCrossRef Yanagisawa, M., H. Kuhihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415.PubMedCrossRef
3.
go back to reference Arinami, T., M. Ishikawa, A. Inoue, M. Yanagisawa, T. Masaki, M. C. Yoshida, and H. Hamaguchi. 1991. Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.213.3. Am. J. Hum. Genet. 48:990–996.PubMed Arinami, T., M. Ishikawa, A. Inoue, M. Yanagisawa, T. Masaki, M. C. Yoshida, and H. Hamaguchi. 1991. Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.213.3. Am. J. Hum. Genet. 48:990–996.PubMed
4.
go back to reference Yoshizumi, M., H. Kurihara, T. Morita, T. Yamashita, Y. Oh-hashi, T. Sugiyama, F. Takaku, M. Yanagisawa, T. Masaki, and Y. Yazaki. 1990. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem. Biophys. Res. Commun. 166:324–329.PubMedCrossRef Yoshizumi, M., H. Kurihara, T. Morita, T. Yamashita, Y. Oh-hashi, T. Sugiyama, F. Takaku, M. Yanagisawa, T. Masaki, and Y. Yazaki. 1990. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem. Biophys. Res. Commun. 166:324–329.PubMedCrossRef
5.
go back to reference Corder, R., M. Carrier, N. Khan, P. Klemm, and J. R. Vane. 1995. Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J. Cardiovasc. Pharmacol. 26(Suppl 3):S56–S58.PubMed Corder, R., M. Carrier, N. Khan, P. Klemm, and J. R. Vane. 1995. Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J. Cardiovasc. Pharmacol. 26(Suppl 3):S56–S58.PubMed
6.
go back to reference Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730–732.PubMedCrossRef Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730–732.PubMedCrossRef
7.
go back to reference Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732–735.PubMedCrossRef Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732–735.PubMedCrossRef
8.
go back to reference Ishida, K., K. Takeshige, and S. Minakami. 1990. ET-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem. Biophys. Res. Commun. 173:496–500.PubMedCrossRef Ishida, K., K. Takeshige, and S. Minakami. 1990. ET-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem. Biophys. Res. Commun. 173:496–500.PubMedCrossRef
9.
go back to reference Fernandez-Patron, C., C. Zouki, R. Whittal, J. S. Chan, S. T. Davidge, and J. G. Filep. 2001. Matrix metalloproteinases regulate neutrophilendothelial cell adhesion through generation of endothelin-1[132]. FASEB. J. 15:2230–2240.PubMedCrossRef Fernandez-Patron, C., C. Zouki, R. Whittal, J. S. Chan, S. T. Davidge, and J. G. Filep. 2001. Matrix metalloproteinases regulate neutrophilendothelial cell adhesion through generation of endothelin-1[132]. FASEB. J. 15:2230–2240.PubMedCrossRef
10.
go back to reference Zouki, C., C. Baron, A. Fournier, and J. G. Filep. 1999. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ETA receptors and platelet-activating factor. Br. J. Pharmacol. 127:969–979.PubMedCrossRef Zouki, C., C. Baron, A. Fournier, and J. G. Filep. 1999. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ETA receptors and platelet-activating factor. Br. J. Pharmacol. 127:969–979.PubMedCrossRef
11.
go back to reference Halim, A., N. Kanayama, E. E. Maradny, K. Maehara, and T. Terao. 1995. Activated neutrophil by ET-1 caused tissue damage in human umbilical cord. Tromb. Res. 77:321–327.CrossRef Halim, A., N. Kanayama, E. E. Maradny, K. Maehara, and T. Terao. 1995. Activated neutrophil by ET-1 caused tissue damage in human umbilical cord. Tromb. Res. 77:321–327.CrossRef
12.
go back to reference Sopata, I., A. M. Dancewics. 1974. Presence of a gelatin specific proteinase and its latent form in human leukocytes. Biochim. Biophys. Acta. 370:510–523.PubMed Sopata, I., A. M. Dancewics. 1974. Presence of a gelatin specific proteinase and its latent form in human leukocytes. Biochim. Biophys. Acta. 370:510–523.PubMed
13.
go back to reference Massova, I., L. P. Kotra, and R. Fridman. 1998. Matrix metalloproteinases: structures, evolution, and diversification. FASEB. J. 12:1075–1095.PubMed Massova, I., L. P. Kotra, and R. Fridman. 1998. Matrix metalloproteinases: structures, evolution, and diversification. FASEB. J. 12:1075–1095.PubMed
14.
go back to reference Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61–65.PubMedCrossRef Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61–65.PubMedCrossRef
15.
go back to reference Hibbs, M. S., K. A. Hasty, J. M. Seyer, A. H. Kang, and C. L. Mainardi. 1985. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260:2493–2500.PubMed Hibbs, M. S., K. A. Hasty, J. M. Seyer, A. H. Kang, and C. L. Mainardi. 1985. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260:2493–2500.PubMed
16.
go back to reference Weissman, G., J. E. Smolen, and H. M. Korchak. 1980. Release of inflammatory mediators from stimulated neutrophils. N. Engl. J. Med. 303:27–34.CrossRef Weissman, G., J. E. Smolen, and H. M. Korchak. 1980. Release of inflammatory mediators from stimulated neutrophils. N. Engl. J. Med. 303:27–34.CrossRef
17.
go back to reference Topham, M. K., H. J. Carveth, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1998. Human endothelial cells regulate polymorphonuclear leukocyte degranulation. FASEB. J. 12:733–746.PubMed Topham, M. K., H. J. Carveth, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1998. Human endothelial cells regulate polymorphonuclear leukocyte degranulation. FASEB. J. 12:733–746.PubMed
18.
go back to reference Schwartz, J. D., S. Monea, S. G. Marcus, S. Patel, K. Eng, A. C. Galloway, P. Mignatti, P. -J. Shamamian. 1998. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. Surgical. Res. 76:79–85.CrossRef Schwartz, J. D., S. Monea, S. G. Marcus, S. Patel, K. Eng, A. C. Galloway, P. Mignatti, P. -J. Shamamian. 1998. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. Surgical. Res. 76:79–85.CrossRef
19.
go back to reference Lamas, S., T. Michel, T. Collins, B. M. Brenner, and P. A. Marsden. 1992. Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J. Clin. Invest. 90:879–887.PubMedCrossRef Lamas, S., T. Michel, T. Collins, B. M. Brenner, and P. A. Marsden. 1992. Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J. Clin. Invest. 90:879–887.PubMedCrossRef
20.
go back to reference Ros, J., A. Leivas, W. Jimenez, M. Morales, M. Bosch-Marce, F. Arroyo, V. Rivera, and J. Rodes. 1997. Effect of bacterial lipopolisacharide on endothelin-1 production in human vascular endothelial cells. J. Hepatol. 26:81–87.PubMedCrossRef Ros, J., A. Leivas, W. Jimenez, M. Morales, M. Bosch-Marce, F. Arroyo, V. Rivera, and J. Rodes. 1997. Effect of bacterial lipopolisacharide on endothelin-1 production in human vascular endothelial cells. J. Hepatol. 26:81–87.PubMedCrossRef
21.
go back to reference Eguchi, S., Y. Hirata, M. Ihara, M. Yano, and F. Marumo. 1992. A novel ETA antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. FEBS. Lett. 302:243–246.PubMedCrossRef Eguchi, S., Y. Hirata, M. Ihara, M. Yano, and F. Marumo. 1992. A novel ETA antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. FEBS. Lett. 302:243–246.PubMedCrossRef
22.
go back to reference Romanic, A. M., R. F. White, A. J. Arleth, E. H. Ohlstein, and F. C. Barone. 1988. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020–1030. Romanic, A. M., R. F. White, A. J. Arleth, E. H. Ohlstein, and F. C. Barone. 1988. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020–1030.
23.
go back to reference Behzadian, M. A., X. L. Wang, L. J. Windsor, N. Ghaly, and R. B. Caldwell. 2001. TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Investig. Ophthalmol. Vis. Sci. 42:853–859. Behzadian, M. A., X. L. Wang, L. J. Windsor, N. Ghaly, and R. B. Caldwell. 2001. TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Investig. Ophthalmol. Vis. Sci. 42:853–859.
24.
go back to reference Zhou, J. Y., and W. W. Dong. 2004. Matrix metalloproteinase-9 expression by endothelial cells incubated with peripheral blood leukocytes from patients with cerebral infarction. Zhonghua Yi Xue Za Zhi. 84:979–981.PubMed Zhou, J. Y., and W. W. Dong. 2004. Matrix metalloproteinase-9 expression by endothelial cells incubated with peripheral blood leukocytes from patients with cerebral infarction. Zhonghua Yi Xue Za Zhi. 84:979–981.PubMed
25.
go back to reference Lin, T. C., C. Y. Li, C. S. Tsai, C. H. Ku, C. T. Wu, C. S. Wong, and S. T. Ho. 2005. Neutrophil-mediated secretion and activation of matrix metalloproteinase-9 during cardiac surgery with cardiopulmonary bypass. Anesth. Analg. 100:1554–1560.PubMedCrossRef Lin, T. C., C. Y. Li, C. S. Tsai, C. H. Ku, C. T. Wu, C. S. Wong, and S. T. Ho. 2005. Neutrophil-mediated secretion and activation of matrix metalloproteinase-9 during cardiac surgery with cardiopulmonary bypass. Anesth. Analg. 100:1554–1560.PubMedCrossRef
Metadata
Title
Endothelins Mediate Neutrophil Activation, ProMMP-9 Release and Endothelial Cell Detachment
Authors
Monica C. Toffoli
Bichoy H. Gabra
Catarina F. P. Teixeira
Pierre Sirois
Sonia Jancar
Publication date
01-04-2007
Published in
Inflammation / Issue 1-2/2007
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-006-9018-7

Other articles of this Issue 1-2/2007

Inflammation 1-2/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.